MedTrace Logo

Docetaxel in Treating Older Women With Metastatic Breast Cancer

NCT00104624 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2013-09-04

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

PURPOSE: This phase II trial is studying how well docetaxel works in treating older women with metastatic breast cancer and whether it helps improve the ability to perform daily activities.

Conditions

Interventions

DRUG

docetaxel

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • UNICANCER

    lead OTHER

Principal Investigators

  • Suzette Delaloge · Gustave Roussy, Cancer Campus, Grand Paris

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2007-07-31
Completion
2008-07-31

Countries

  • France
  • Italy
  • Switzerland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00104624 on ClinicalTrials.gov